Tryton Medical: Built for Bifurcation

Located in Durham, N.C., Tryton Medical, Inc. is a leading developer of novel stent systems for the treatment of bifurcation lesions. The company was founded in 2003 by Aaron V. Kaplan, M.D. (professor of medicine at Dartmouth Medical School/Dartmouth- Hitchcock Medical Center) and Dan Cole to develop stents for the definitive treatment of bifurcation lesions.

Tryton Fact
Tryton Ticker
Tryton Infographic


The Tryton Side Branch Stent System uses proprietary Tri-ZONE™ technology to offer a dedicated strategy for treating bifurcation lesions. Tryton is the first and only coronary bifurcation stent  to receive CE Mark for Left Main Indication.